| Myeloproliferative Neoplasm, BCR-ABL1 Negative investigated in trials for …INVESTIGATED_IN_TRIALSderived98 of 98show fewer |
|---|
| → investigated in trials for | Ruxolitinibsmall molecule 43 trials (17 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 31 trials (4 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 24 trials (6 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ropeginterferon Alfa-2bother 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fedratinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2aother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lestaurtinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Momelotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anagrelidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elotuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxycarbamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rigosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Myeloproliferative Neoplasm, BCR-ABL1 Negative | 1 | Observed | clinicaltrials | graph → |